Qiu et al., 2012 - Google Patents
Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirusQiu et al., 2012
View PDF- Document ID
- 3385949790522067268
- Author
- Qiu X
- Hong C
- Li Y
- Bao W
- Gao X
- Publication year
- Publication venue
- Microbiology and immunology
External Links
Snippet
ABSTRACT Fragment 450–650 of the spike (S) protein (S450–650) of severe acute respiratory syndrome‐associated coronavirus (SARS‐CoV) contains epitopes capable of being recognized by convalescent sera of SARS patients. Vaccination of mice with …
- 102000004082 Calreticulin 0 title abstract description 60
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55516—Proteins; Peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Sebo et al. | Adenylate cyclase toxin-hemolysin relevance for pertussis vaccines | |
Wang et al. | Enhanced influenza virus-like particle vaccines containing the extracellular domain of matrix protein 2 and a Toll-like receptor ligand | |
Testa et al. | MHC class I-presented T cell epitopes identified by immunoproteomics analysis are targets for a cross reactive influenza-specific T cell response | |
Gaspar et al. | Experimental studies using OMV in a new platform of SARS-CoV-2 vaccines | |
Tsybalova et al. | Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine | |
Alves et al. | Production of a recombinant dengue virus 2 NS5 protein and potential use as a vaccine antigen | |
von Gersdorff Jørgensen et al. | Rainbow trout (Oncorhynchus mykiss) immune response towards a recombinant vaccine targeting the parasitic ciliate Ichthyophthirius multifiliis | |
Deng et al. | Immunogenicity of recombinant human bocavirus‐1, 2 VP 2 gene virus‐like particles in mice | |
Akache et al. | Immunogenicity of SARS-CoV-2 spike antigens derived from Beta & Delta variants of concern | |
Verma et al. | Norovirus (NoV) specific protective immune responses induced by recombinant P dimer vaccine are enhanced by the mucosal adjuvant FlaB | |
Wang et al. | Self-assembling ferritin nanoparticles coupled with linear sequences from canine distemper virus haemagglutinin protein elicit robust immune responses | |
He et al. | A recombinant spike‐XBB. 1.5 protein vaccine induces broad‐spectrum immune responses against XBB. 1.5‐included Omicron variants of SARS‐CoV‐2 | |
Fernández et al. | Conformational and thermal stability improvements for the large-scale production of yeast-derived rabbit hemorrhagic disease virus-like particles as multipurpose vaccine | |
Aparicio et al. | Preclinical evaluation of a synthetic peptide vaccine against SARS-CoV-2 inducing multiepitopic and cross-reactive humoral neutralizing and cellular CD4 and CD8 responses | |
Lu et al. | DNA vaccine ROP 29 from Toxoplasma gondii containing R848 enhances protective immunity in mice | |
Xu et al. | The N‐terminal D1 domain of Treponema pallidum flagellin binding to TLR5 is required but not sufficient in activation of TLR5 | |
Song et al. | A candidate nanoparticle vaccine comprised of multiple epitopes of the African swine fever virus elicits a robust immune response | |
Qiu et al. | Calreticulin as a hydrophilic chimeric molecular adjuvant enhances IgG responses to the spike protein of severe acute respiratory syndrome coronavirus | |
Jang et al. | Immune-engineered H7N9 influenza hemagglutinin improves protection against viral influenza virus challenge | |
Zhang et al. | Antigenic and immunogenic properties of recombinant proteins consisting of two immunodominant African swine fever virus proteins fused with bacterial lipoprotein OprI | |
Arikata et al. | Memory immune responses against pandemic (h1n1) 2009 influenza virus induced by a whole particle vaccine in cynomolgus monkeys carrying mafa-A1* 052∶ 02 | |
Khateri et al. | Evaluation of autophagy induction on HEV 239 vaccine immune response in a mouse model | |
CN103724405B (en) | Type A foot-and-mouth disease CTL (cytotoxic T lymphocyte) epitope peptide and screening method thereof | |
Sun et al. | Inactivated Pseudomonas PE (ΔIII) exotoxin fused to neutralizing epitopes of PEDV S proteins produces a specific immune response in mice | |
Ji et al. | Embedding of exogenous B cell epitopes on the surface of UreB structure generates a broadly reactive antibody response against Helicobacter pylori |